Drug Shortage Report for TWYNSTA
Report ID | 131370 |
Drug Identification Number | 02371022 |
Brand name | TWYNSTA |
Common or Proper name | TWYNSTA 40/5MG 4X7 |
Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
Market Status | MARKETED |
Active Ingredient(s) | TELMISARTAN AMLODIPINE |
Strength(s) | 40MG 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | BLISTER PACK 4X7 |
ATC code | C09DB |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-01-12 |
Actual start date | 2021-01-11 |
Estimated end date | 2021-01-20 |
Actual end date | 2021-01-15 |
Shortage status | Resolved |
Updated date | 2021-01-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2021-01-16 | English | Compare |
v5 | 2021-01-15 | French | Compare |
v4 | 2021-01-15 | English | Compare |
v3 | 2021-01-12 | English | Compare |
v2 | 2021-01-11 | French | Compare |
v1 | 2021-01-11 | English | Compare |
Showing 1 to 6 of 6